Halozyme Therapeutics (HALO)
(Delayed Data from NSDQ)
$38.64 USD
+0.83 (2.20%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $38.64 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth D Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $0.69 | -5.80% |
Earnings Summary
For their last quarter, Halozyme Therapeutics (HALO) reported earnings of $0.82 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for HALO's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of $0.69 per share, reflecting a year-over-year increase of 46.81%.
Earnings History
Price & Consensus
Zacks News for HALO
Halozyme Therapeutics (HALO) Upgraded to Buy: Here's What You Should Know
HALO: What are Zacks experts saying now?
Zacks Private Portfolio Services